|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/05 | |
| A61K 45/06 | |||
| A61P 25/08 | |||
| A61K 9/00 | |||
| A61K 9/08 |
| (11) | Patento numeris | 3160457 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15733514.2 |
| Europos patento paraiškos padavimo data | 2015-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2015/051894 |
| Data | 2015-06-29 |
| (87) | Numeris | WO 2015/198078 |
| Data | 2015-12-30 |
| (30) | Numeris | Data | Šalis |
| 201411496 | 2014-06-27 | GB |
| (72) |
STOTT, Colin, GB
JONES, Nick, GB
WHALLEY, Benjamin, GB
STEPHENS, Gary, GB
WILLIAMS, Claire, GB
|
| (73) |
GW Research Limited,
Sovereign House, Vision Park Histon, Cambridge, CB24 9BZ,
GB
|
| (54) | 7-HYDROXY-CANNABIDIVARIN (7-OH-CBDV) FOR USE IN THE TREATMENT OF EPILEPSY |
| 7-HYDROXY-CANNABIDIVARIN (7-OH-CBDV) FOR USE IN THE TREATMENT OF EPILEPSY |